Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of July 6th – 12th, 2020.

Without further ado, let’s get started.

* Yahoo Finance readers, please click here to view full article.

10. TCI Insider Trading Report: Top Cannabis Stocks with Recent Insider Trading Activity

The TCI Insider Trading Report is a New Biweekly Segment Focused on Showcasing Recent Insider Transactions From the Cannabis Sector’s Biggest Names

Staying up to date on insider trading activity is essential and many investors use this information to help predict the future trend of a sector or an individual stock. Without further delay, here’s a recap of the past month’s insider trading activity from the most noteworthy Cannabis Stocks.

READ FULL TCI INSIDER TRADING REPORT

9. Canada: Legal and Regulatory Landscape for Psychedelics Companies Considering “Going Public” in Canada

Over the Past Few Months, Many of the Most Active Stocks on the CSE Have Been Shares of Companies Involved in the Psychedelics Industry

Companies working in the Psychedelics industry have also listed on the TSX Venture Exchange and the NEO Exchange in Canada. Several other companies in the sector are actively raising capital from the investment community to develop their business, and have plans to “go public” in Canada.

READ FULL PSYCHEDELICS SECTOR ARTICLE

8. Horizons ETFs Rebalances Marijuana-Focused Index ETF Suite

HMMJ is the World’s First ETF That Offered Direct Exposure to Businesses with Activities in the Marijuana Industry and This Quarter, HMMJ Added Two Constituents to its Portfolio

Horizons ETFs Management (Canada) has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF HMMJ and the Horizons U.S. Marijuana Index ETF HMUS.

READ FULL CANNABIS ETFS ARTICLE

7. Aleafia Completes Outdoor Planting on 66 Acres

It Appears That Poor Sector Tailwinds Have Yet to Slow Down Aleafia and its Cultivation Plans

Aleafia Health ALEAF issued a corporate update announcing that they had completed the planting of their outdoor crop, while simultaneously scaling up their greenhouse operations.

READ FULL ALEAFIA ARTICLE

6. MagicMed Industries Files First Psychedelic Derivative Patent

The Patent Filing is Anticipated to Be the First in a Series of Applications That Together Will Protect the Company’s Broad Portfolio of Novel Psilocybin Molecular Derivatives

MagicMed Industries announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) covering composition of matter, drug formulation and process of preparation claims for novel Psilocybin derivatives.

READ FULL MAGICMED ARTICLE

5. Cansortium Has Turned a Corner, Says Paradigm Capital

Positive EBITDA in its Latest Quarterly Results Are a Sign of Things to Come for U.S. Cannabis Name Cansortium Says Paradigm Capital Analyst Corey Hammill

Cansortium CNTMF is a medical cannabis company with vertically integrated cultivation, processing, formulation and sales through its patient platform, with operations based in Florida’s medical market but also with interests in Texas, Michigan and Pennsylvania.

READ FULL CANSORTIUM ARTICLE

4. ATAI Life Sciences Takes on Opioid Crisis By Acquiring Kures to Develop Novel Therapeutics for Opioid Abuse

ATAI is a Global Biotechnology Company Builder That Envisions an End to Mental Illnesses

ATAI Life Sciences has acquired a majority stake in New York-based pharmaceutical company Kures, which targets the important intersection between pain and opioid use disorder. Additionally, Srinivas Rao, MD, PhD, Chief Scientific Officer of ATAI Life Sciences, has been appointed CEO of Kures.

READ FULL ATAI ARTICLE

3.Green Thumb Industries is a Top Pick for Q3, Says Echelon

Echelon Analyst Andrew Semple Renewed GTII’s Status as a Top Pick in a Report to Clients

Semple has put Green Thumb GTBIF into Echelon’s Top Picks Portfolio for the last three quarters, where the stock outperformed the tracking group average for all those time periods, including for the Q2 where GTII returned a massive 65%.

READ FULL GTII ARTICLE

2. CannaGlobal, Sansero Life Sciences and Rise Wellness Merge to Create a New International Psychedelics Company

Leveraging an Internationally Renowned Team with a Track Record of Success, the Company Will Be Ideally Positioned in the Evolving Psychedelics Industry

CannaGlobal, Sansero Life Sciences, and Rise Wellness announced the creation of CannaGlobal Wellness, a global Psychedelics leader focused on Psilocybin and other natural compounds to promote emotional, mental, and physical wellness.

READ FULL CANNAGLOBAL ARTICLE

1. 3 Reasons Why It’s the Right Time to Buy Trulieve Cannabis

Its Dominance in One State and Staggering Growth From Just Medical Cannabis Show its Potential to Thrive, But There Could Be Some Risk

When it comes to cannabis in Florida, Trulieve is the company that comes to mind. There are, of course, other players in the state, but Trulieve Cannabis TCNNF has captured a good chunk of the retail space with 51 dispensaries. The company now operates a total of 53 dispensaries in the U.S., with the other two in California and Connecticut.

READ FULL TRULIEVE ARTICLE

Photo by Rick Proctor on Unsplash